France 2030 is a venture capital fund specializing in early-stage investments in energy, climate tech, health tech, and biotech. Typically providing financial support between $500,000 and $10,000,000, the fund has backed companies like HEPHAISTOS-Pharma and Arkeon Energy Systems. France 2030 bridges academia and industry, enhancing both basic and applied research to elevate French research and foster new partnerships. Since 2010, it has also managed Investments for the Future, selecting, funding, and monitoring projects in higher education and research.
